Gene therapy is becoming a reality for the treatment of several conditions, but preclinical evaluation still presents a challenge 1. Adverum Biotechnologies overcame these hurdles to achieve FDA ...

Although investigators were initially overexuberant in their quest to treat inherited diseases by gene therapy, it has become clear that the chief candidates are likely to be acquired diseases.